Skip to main content
. 2022 May 27;12:884411. doi: 10.3389/fcimb.2022.884411

Figure 6.

Figure 6

Feasibility of the N. farcinica CRISPR-CLA assay using clinical samples. (A) The fluorescence N. farcinica CRISPR-CLA assay results. Sample S1 to S21 showed positive results and sample N1 to N20 showed negative. (n = 3 technical replicates; bars represent mean ± s.e.m.) (B) The lateral-flow N. farcinica CRISPR-CLA assay results. Sample S1 to S21 showed positive results and sample N1 to N20 showed negative. S1-S20, simulated positive samples; S21, positive sample; N1-N20, negative samples; PC, positive control; NC, negative control; BC, blank control.